Page last updated: 2024-09-03

ilomastat and gm 1489

ilomastat has been researched along with gm 1489 in 1 studies

Compound Research Comparison

Studies (ilomastat)	Trials (ilomastat)	Recent Studies (post-2010) (ilomastat)	Studies (gm 1489)	Trials (gm 1489)	Recent Studies (post-2010) (gm 1489)
103	0	45	12	0	8

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Golub, LM; Kocer, SS; Simon, SR; Walker, SG; Zerler, B	1

Other Studies

1 other study(ies) available for ilomastat and gm 1489

Article	Year
Metalloproteinase inhibitors, nonantimicrobial chemically modified tetracyclines, and ilomastat block Bacillus anthracis lethal factor activity in viable cells. Infection and immunity, 2005, Volume: 73, Issue:11 Topics: Animals; Antigens, Bacterial; Bacillus anthracis; Bacterial Toxins; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Hydroxamic Acids; Indoles; MAP Kinase Kinase 2; MAP Kinase Kinase 6; Metalloproteases; Protein Processing, Post-Translational; Tetracyclines; Tryptophan	2005

Article

Year

Metalloproteinase inhibitors, nonantimicrobial chemically modified tetracyclines, and ilomastat block Bacillus anthracis lethal factor activity in viable cells.

Infection and immunity, 2005, Volume: 73, Issue:11

Topics: Animals; Antigens, Bacterial; Bacillus anthracis; Bacterial Toxins; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Hydroxamic Acids; Indoles; MAP Kinase Kinase 2; MAP Kinase Kinase 6; Metalloproteases; Protein Processing, Post-Translational; Tetracyclines; Tryptophan

2005